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Abstract
Objectives: Endovascular repair of the descending thoracic aorta is a very promising technique in elective and, particularly, emergency
situations. This study assessed the impact of urgency of the procedure on outcome and mid-term quality of life in surviving patients. Methods:
Post hoc analysis of prospectively collected data of 58 consecutive patients (January 2001—December 2005) with surgical pathologies of the
descending thoracic aorta treated by endovascular means. Six patients were excluded due to recent operations on the ascending aorta before
thoracic endovascular repair. The remaining patients (n = 52) were 69  10 years old, and 43 were men (83%). Twenty-seven had been treated
electively, and 25 for emergency indications. Reasons for emergency were acute type B aortic dissections with or without malperfusion syndrome
in 14, and aortic ruptures in 11 cases. Follow-up was 29  16 months. Endpoints were perioperative and late morbidity and mortality rates and
long-term quality of life as assessed by the short form health survey (SF-36) and Hospital Anxiety and Depression Scale questionnaires. Results:
Cohorts were comparable regarding age, sex, cardiovascular risk factors, and comorbidities. Perioperative mortality was somewhat higher in
emergency cases (12% vs 4%, p = 0.34). Paraplegia occurred in one patient in each cohort (4%). Overall quality of life after two and a half years was
similar in both treatment cohorts: 72 (58—124) after emergency, and 85 (61—105) after elective endovascular aortic repair ( p = 0.98). Normal
scores range from 85 to 115. Anxiety and depression scores were in the normal range and comparable. Conclusions: Thoracic endovascular aortic
repair is an excellent and safe treatment option for the diseased descending aorta, particularly in emergency situations. Early morbidity and
mortality rates can be kept very low. Mid-term quality of life was not affected by the urgency of the procedure. Similarly, mid-term anxiety and
depression scores were not increased after emergency situations.
# 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Surgery of the descending thoracic aorta is technically
very demanding and associated with substantial mortality
and morbidity rates [1,2]. Thoracic endovascular aortic
repair (TEVAR) using covered stent grafts represents an
attractive alternative to open aortic repair (OAR) because it
allows less invasive exclusion of the aortic pathology from the
circulation. The advantages of the endovascular approach
with its minimised access trauma and remote vascular access
might be important. In the perioperative period, endovas-§ Florian Dick received independent stipendiary support for a vascular
research fellowship from the Swiss National Funds (SNF, PBBSB-120858) and
the Lichtenstein Stiftung, Basel, Switzerland, during part of his time.
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doi:10.1016/j.ejcts.2008.08.019cular repair has been shown to confer considerable benefit to
the patient in treatment of both thoracic and abdominal
aortic aneurysms (TAA and AAA, respectively) [2,3]. The
thoracic aorta, however, poses several unique technical
challenges which may affect long-term results, and which
have hampered simple adaptation and transfer of endovas-
cular devices and technology which were originally devel-
oped for the abdominal aorta [2,4]. Nonetheless TEVAR has
become a valuable alternative to OAR not only in elective,
but particularly in emergency situations. Recent studies have
shown better outcomes regarding mortality and paraplegia
rates than after emergency OAR [5—7]. The specific technical
demands of TEVAR, however, may be particularly difficult to
meet in emergency situations and therefore unfavourably
impact on long-term outcome. Additionally, the traumatic
experience of an aortic emergency might lead to increased
anxiety or depression levels.urgery. Published by Elsevier B.V. All rights reserved.
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recognised as a pivotal outcome dimension in invasive vascular
medicine [8]. Indeed, survivors may subjectively experience
QoL as the single most important indicator of treatment
success. Long-term QoL after TEVAR has only been assessed in
smaller collectives so far [9,10], and it is unknown whether
urgency of TEVAR negatively affects QoL during follow-up. The
aim of this single centre series therefore was to assess out-
come and postoperative QoL in surviving patients after TEVAR
and to relate them to an age- and gender-matched standard
population after stratification for urgency of initial treatment.2. Materials and methods
We conducted a post hoc analysis of a prospectively
registered consecutive series of 58 patients who were
treated by TEVAR for thoracic aortic disease between
January 2001 and December 2005. Analysis of data was
approved by the local ethics committee, and informed
consent was obtained from each patient. Recorded patient
details included demographic characteristics, pre-existent
comorbidities, cardiovascular risk factors as well as history of
previous cardiovascular surgery, clinical presentation, ima-
ging studies, diagnosis, intra-operative details as well as
early (i.e. 30 days or in-hospital) morbidity and mortality.
Identification of cardiovascular risk factors was based upon
previously published definitions [11]. Cut-off value for
diagnosis of a TAA was a maximum aortic diameter of at
least 3 cm. In order to minimise independent influences on
long-term QoL, six patients were excluded from analysis
because they had undergonemajor cardiothoracic surgery for
treatment of pathologies of the aortic root, ascending aorta
or aortic arch within the previous three years of personal
history before being included into this study. The remaining
52 patients were 69  10 years old, and 43 were men (83%).
All patients were followed systematically after interven-
tion in annual intervals within a specialised outpatient clinic.
Follow-up data were thereby recorded prospectively. Addi-
tional outpatient visits were arranged according to clinical
needs.
Cross-sectional assessment of present-day QoL was
performed after a mean follow-up of 29  16 months
utilising the validated German versions of both the short
form health survey (SF-36) and the Hospital Anxiety and
Depression Scale (HADS) questionnaires [12—14]. Question-
naires were sent a second time to non-responders before
they were contacted by phone. Results were stratified for
the urgency of treatment.
2.1. Study endpoints
Perioperative mortality and morbidity included all events
within 30 days of treatment or whenever patients were still in
hospital. Cumulative mid-term survival was assessed accord-
ing to the method proposed by Kaplan and Meier [15]. QoL
was assessed by means of the self administered SF-36 and the
HADS questionnaires. Details of the validated German version
of the SF-36 have been published previously [16]. Briefly, the
SF-36 consists of 36 short questions reflecting QoL in eight
different aspects: bodily pain (2 items); mental health (5items); vitality (4 items); social functioning (2 items);
general health (5 items); physical functioning (10 items);
and role functioning, both emotional (3 items) and physical
(4 items). Role functioning reflects the impact of emotional
and physical disability on work and regular activity
(the individual’s normal everyday role). Raw points generate
a score for each dimension, which add up to a total raw score
ranging from 0 to 100, with 100 reflecting best functioning.
Raw scores then were adjusted for age and gender of the
study population by multiplication with the appropriate
factor based on a validated Western European Standard
population (n = 8930, Sweden) according to the SF-36 manual
[13], thereby generating an adjusted score. Normal values
for the adjusted score range from 85 to 115. The aspects
anxiety and depression were assessed additionally with the
HADS. This questionnaire allows to assess psychic restrictions
in patients with somatic disorders [14].
2.2. Statistical methods
Normally distributed variables are summarised as mean (
1 SD), and were compared by two-tailed unpaired t-test.
Asymmetrically distributed variables are represented as
median (interquartile range), and were compared by two-
sided Mann—Whitney U test. Categorical variables are
presented as numbers (percentages) and were compared by
two-tailed Fisher’s exact test. Additionally, odds ratios were
calculated including 95% confidence intervals. The SF-36
questionnaire was analysed in accordance with the SF-36
manual, replacing missing values using the described algo-
rithm [12,13]. After arithmetical adjustment for age and
gender SF-36 scores were compared by means of Mann—
Whitney U test. Results were stratified for urgency of
intervention. A p value of less than 0.05 was considered to
indicate statistical significance. Datawere analysed using SPSS
for Windows, version 15.0.3. Results
Fifty-two patients were analysed for the purpose of this
study: 27 had been treated electively (52%), and 25 under
emergency conditions (48%). Demographic characteristics as
well as pre-, intra- and postoperative data of the treatment
cohorts are summarised in Tables 1 and 2. Patients were
comparable regarding age, sex and cardiovascular risk factors
with exception of a higher prevalence of recorded dyslipi-
daemia in electively treated patients. Similarly, prevalence of
assessed comorbidities was comparable in both treatment
cohorts (Table 1). Early mortality rates were similar in both
cohorts (4% vs 12%, p = 0.34 by two-tailed Fisher’s exact test).
Overall early mortality rate was 8% (n = 4).
Characteristics of aortic disease are summarised in
Table 1. Prevalence of aneurysmatic disease was similar,
whereas aortic ruptures naturally only occurred in the
emergency cohort ( p < 0.001 by two-tailed Fisher’s exact
test). Other emergency indications for TEVAR were acute
type B aortic dissections associated with treatment resistant
symptoms (n = 4) or visceral malperfusion syndrome (n = 3).
One patient was operated urgently for a symptomatic aortic
pleb in the proximal descending aorta. Patients stayed
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Table 1
Demographic characteristics of 58 patients treated for diseased descending aorta by TEVAR
Elective TEVAR (n = 29) Emergency TEVAR
(n = 29)
OR (95% CI) p value
Excluded patients, n (%) 2 (7%) 4 (14%) 0.46 (0.09—2.40) 0.678
Analysed patients, n (%) 27 (93%) 25 (86%)
Mean age  SD (years) 71  8 67  12 — 0.15*
Male gender, n (%) 23 (85%) 20 (80%) 1.44 (0.36—5.68) 0.728
Cardiovascular risk factors
Diabetes, n (%) 6 (22%) 2 (8%) 3.29 (0.67—15.70) 0.258
Arterial hypertension 21 (78%) 20 (80%) 0.88 (0.24—3.18) 1.08
Hyperlipidaemia 16 (59%) 6 (24%) 4.61 (1.42—14.88) 0.0138
Tobacco use 17 (63%) 9 (36%) 3.02 (0.99—9.22) 0.0958
Obesity 4 (15%) 3 (12%) 1.28 (0.28—5.71) 1.08
Comorbidities
COPD, n (%) 7 (26%) 4 (16%) 1.84 (0.49—6.82) 0.508
CHD, n (%) 16 (59%) 2a (8%) —
History of myocardial infarction, n (%) 1 (4%) 0 — 1.08
Family history of cardiovascular disease, n (%) 5 (19%) 4 (16%) 1.19 (0.30—4.71) 1.08
Renal insufficiency 8 (30%) 4 (16%) 2.21 (0.60—8.05) 0.338
History of major thoracic cardiovascular surgery, n (%)b 10 (37%) 6 (24%) 1.86 (0.57—6.03) 0.388
Neoplasia, n (%) 4 (15%) 2 (8%) 2.00 (0.38—10.24) 0.678
Characterisation and localisation of treated aortic pathology
Thoracic aneurysm, n (%) 20 (74%) 17 (68%) 1.35 (0.42—4.35) 0.548
Median aneurysm diameter (mm) 55 (50—73) 40 (39—56) — 0.021#
Rupture 0 11 (65%) — <0.0018
Marfan disease, n (%) 1 (6%) 0 — 1.08
Type B dissection without aneurysm, n (%) 5 (19%) 4 (16%) 1.19 (0.30—4.71) 1.08
Other pathologies of thoracic segment of aorta
including malperfusion syndrome, n (%)
2 (7%) 4 (16%) 0.42 (0.08—2.20) 0.618
Demographic characteristics as well as characteristics of local disease of 58 patients undergoing elective or emergency TEVAR of descending aortic disease between
January 2001 and December 2005. Results are displayed as absolute figures (percentage), as mean values  1 SD, or as median (interquartile range).
COPD: chronic obstructive pulmonary disease; CHD: coronary heart disease; TEVAR: thoracic endovascular aortic repair; OR: odds ratio; CI: confidence interval.
a In emergency procedures recent coronary angiographies were often not available.
b Only patients with previous thoracic cardiovascular surgery more than three years earlier were included, six patients with more recent thoracic operations were
excluded.
8 Calculated by two-tailed Fisher’s exact test.
* Calculated by two-tailed unpaired t-test.
# Calculated by Mann—Whitney U test.significantly longer on intermediate care unit (ICU) after
emergency TEVAR. However, overall length of hospital stay
was not different from elective TEVAR patients (Table 2).
Perioperativemorbidity as well as incidence of early revisions
was similar in both cohorts (Table 2).
3.1. Interventions
Median intervention timeswere similar in elective (145 min
[120—310]) and emergency TEVAR (140 min [100—167];
p = 0.26 by two-sided Mann—Whitney U test). Similarly, the
amounts of contrast agent used (230 ml [190—320] vs 250 ml
[150—350]; p = 0.75) and of fluoroscopy time (14 min [10—24]
vs 15 min [11—35]; p = 0.73), were comparable. Femoral
rather than iliac access was chosen more often in emergency
TEVAR although not statistically significantly (80% vs 63%,
p = 0.23 by two-sided Fisher’s exact text). The left subclavian
artery was overstented more often in emergency TEVAR (32%)
than in elective TEVAR (22%), again without statistical
significance (p = 0.54). However, no patient suffered from
ischaemic symptoms of the left arm later on nor were
neurologic sequelae in the vertebrobasilar region registered.
Endovascular fenestrations of dissection membranes wereperformed in three cases (6%), two of whichwithin emergency
procedures (p = 0.60). Intra-operative conversion to OAR was
necessary in two patients (4%, one patient in each treatment
cohort). In both patients, type 2 endoleaks were the reason
for conversion. The overall incidence of endoleaks (n = 11)was
higher after elective TEVAR (37% vs 4%, p = 0.005). However,
only two of them eventually needed revision procedures
(p = 0.49), whereas seven patients were treated conser-
vatively. Another patient of the emergency TEVAR cohort
required a reintervention within the first postoperative
month, which was related to a proximal extension of an acute
type B aortic dissection despite TEVAR. Hence, the resulting
type A aortic dissection required open replacement of the
ascending aorta and aortic arch. During follow-up, no further
reinterventions were needed in this cohort, whereas one late
reintervention (18 months) was necessary in the elective
TEVAR cohort due to a type 2 endoleak with increasing
diameter of the excluded aneurysm.
3.2. Follow-up
Mean length of follow-up was around two and a half years
in both treatment cohorts ( p = 0.55 by Mann—Whitney U test,
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Table 2
Early postoperative course of 52 analysed patients
Elective TEVAR (n = 27) Emergency TEVAR (n = 25) OR (95% CI) p value
Postoperative (30 days)
Median length of stay ICU (days) 0 (0—1) 2 (0.75—4.5) — 0.001#
Median length of stay in hospital (days) 8 (5—14) 8.5 (7—15) — 0.88#
Early mortality, n (%) 1 (4%) 3 (12%) 0.28 (0.04—2.16) 0.348
Early morbidity
Cerebrovascular incident, n (%) 3 (11%) 2 (8%) 1.44 (0.26—7.86) 1.08
Paraparesis or plegia, n (%) 4 (15%) 4 (16%) 0.91 (0.22—3.80) 1.08
New renal insufficiency, n (%) 2 (7%) 3 (12%) 0.59 (0.11—3.26) 0.668
Temporary dialysis, n (%) 0 0 — 1.08
Myocardial infarction, n (%) 0 2 (8%) — 0.238
Pneumonia, n (%) 2 (7%) 0 — 0.498
Tracheostomy, n (%) 2 (7%) 2 (8%) 0.92 (0.15—5.68) 1.08
Sepsis, n (%) 1 (4%) 0 — 1.08
Early revisions, n (%) 5 (19%) 4 (16%) 1.19 (0.30—4.71) 1.08
Bleeding, n (%) 1 (4%) 2 (8%) 0.44 (0.06—3.66) 0.608
Endoleak or stent-graft extension, n (%) 2 (7%) 2 (8%) 0.92 (0.15—5.68) 1.08
Wound infection, n (%) 1 (4%) 0 — 1.08
Other 1 (4%) 0 — 0.488
Results are displayed as absolute figures (percentage), or as median (interquartile range).
ICU: intermediate care unit; TEVAR: thoracic endovascular aortic repair; OR: odds ratio; CI: confidence interval.
8 Calculated by two-tailed Fisher’s exact test.
# Calculated by Mann—Whitney U test.Table 3). After the perioperative period, 10 patients died
during follow-up accounting for cumulative survival rates of
72% (elective TEVAR), and 70% (emergency TEVAR) after
three years ( p = 0.79 by log rank test, Fig. 1). Therefore, 38
patients were eligible for QoL assessment at cross-sectional
follow-up. All patients could be contacted and were sent the
SF-36 and HADS questionnaires (no loss of follow-up). Out of
these, 27 were returned (71%). The return rates were equal in
both treatment cohorts: 70% (elective TEVAR), and 72%
(emergency TEVAR, p = 1.0 by two-tailed unpaired Fisher’s
exact test). Three patients were unable to fill out theFig. 1. Kaplan—Meier survival curves for patients undergoing elective (n = 27questionnaire due to language problems. The remaining eight
patients refused to fill out the questionnaires. However, all
these patients have been contacted by phone and were alive.
Mid-term overall QoL was assessed by the SF-36, and
scores were comparable in both treatment cohorts after
adjustment for age and gender: 85 (61—105) after elective,
and 72 (58—124) after emergency TEVAR, respectively
( p = 0.98 by Mann—Whitney U test). However, both cohorts
scored lower than what would be expected from a
corresponding standard population which scores between
85 and 115. The eight individual QoL dimensions are) and emergency (n = 25) thoracic endovascular aortic repair (TEVAR).
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Table 3
Follow-up and long-term quality of life in 38 surviving patients
Elective TEVAR (n = 27) Emergency TEVAR (n = 25) OR (95% CI) p value
Eligible patients, n (%) 20 (74%) 18 (72%) 1.11 (0.34—3.67) 1.08
Follow-up completed (QoL), n (%) 14 (70%) 13 (72%) 0.90 (0.23—3.51) 1.08
Mean follow-up  SD (months) 27  17 31  16 0.55#
Quality of life (SF-36)
Median physical function 85 (55—93) 60 (45—104) 0.41#
Median role physical 69 (0—137) 0 (0—126) 0.48#
Median bodily pain 84 (33—135) 102 (66—140) 0.20#
Median general health 89 (58—105) 96 (76—131) 0.74#
Median vitality 81 (34—106) 54 (37—122) 0.92#
Median social function 97 (78—113) 94 (79—114) 0.87#
Median role emotional 111 (56—116) 56 (0—116) 0.51#
Median mental health 97 (78—121) 106 (87—113) 0.60#
Overall physical health 82 (58—114) 70 (61—127) 0.80#
Overall mental health 92 (52—109) 78 (60—119) 0.98#
Overall SF-36 85 (61—105) 72 (58—124) 0.98#
Anxiety and depression (HADS)
Median anxiety 4.0 (2.0—7.0) 5.0 (3.5—6.0) 0.79#
Median depression 5.0 (3.5—6.0) 5.0 (3.0—8.0) 0.85#
Long-term quality of life as assessed in 27 survivors 30 months after endovascular treatment of descending thoracic aortic disease. Short form 36 health survey data
are corrected for age and gender. Values are given as median (interquartile range). Values lower than 85 reflect a significant impairment in quality of life as compared
to data obtained in a standard population. Overall physical health includes the physical domains (physical function, physical role, bodily pain, and general health).
Overall mental health includes the mental domains (vitality, social function, emotional role, and mental health). Anxiety and depression as assessed by the Hospital
Anxiety and Depression Scale questionnaire are displayed as median values (interquartile range), higher values reflecting higher anxiety and/or depression.
TEVAR: thoracic endovascular aortic repair; OR: odds ratio; CI: confidence interval.
8 Calculated by two-tailed Fisher’s exact test.
# Calculated by Mann—Whitney U test.described in detail in Table 3 and are shown in Fig. 2. No
statistically significant differences could be found between
the cohorts in any of the assessed dimensions by non-
parametric testing. Importantly, both cohorts scored in the
key dimension mental health in the same and normal rangeFig. 2. Long-term quality of life in patients undergoing elective (n = 27) and emergenc
27 were assessed by the short form 36 health questionnaire (71%). Results are displa
standard populations score between 85 and 115 points (dotted lines).rendering them actually comparable for all other domains of
the SF-36. This observation was supported by the results of
the specific depression and anxiety subscale in the HADS
questionnaire, which showed identical scores in a normal
range for both cohorts (Table 3, and Fig. 3).y (n = 25) thoracic endovascular aortic repair (TEVAR). Of 38 surviving patients,
yed as median scores, values are given in Table 3. Age- and gender-adjusted
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Fig. 3. Hospital anxiety and depression scale (HADS) results in patients under-
going elective (n = 27) and emergency (n = 25) thoracic endovascular aortic
repair (TEVAR). Of 38 surviving patients, 27 were assessed (71%). Results are
displayed asmedian scores; values are given in Table 3. Higher values reflect an
increase in anxiety and depression aspects. Normal anxiety levels range below
11, and normal depression levels range below 9 (dotted lines).4. Discussion
This consecutive single centre series analysed the mid-
term results of an unselected collective of 58 TEVAR patients
who had undergone thoracic aortic repair for a variety of
vascular pathologies between January 2001 and December
2005. Both general outcome and subjective health related
QoL were scrutinised after amean follow-up of two and a half
years with stratification for urgency of TEVAR. Key finding was
that self-reported QoL, while markedly impaired when
compared to an age- and gender-adjusted standard popula-
tion, was not influenced by urgency of TEVAR despite the fact
that requirements for successful TEVAR might be more
difficult to meet under emergency conditions.
Open surgical access to the thoracic aorta is technically
demanding and may be particularly complication-prone in
emergency situations where pressure of time may impede
stepwise exposure. Typical complications range from access
related morbidity to intra- or postoperative bleeding and
cerebral or peripheral embolism to spinal cord ischaemia with
consecutive paraplegia or paraparesis [1]. Many of these
complications are at least theoretically much less probable
with a remote endovascular approach [1]. Indeed, with rising
experience in thoracic endovascular interventions and tech-
nical improvements of catheters, guide wires, stent material
and delivery systems, TEVAR has now become an important
alternative to OAR in the thoracic aorta [5—7].
Based on data published in recent years, acceptable
perioperative mortality rates for elective TEVAR range from
1.2% to 9.3% [2,17—19], which are very consistent with our
findings (early mortality after elective TEVAR 4%). Mortality
rates of elective open thoracic aortic repair are usually
reported between 5% and 14% [1], and a recent population-based survey found an elective mortality of open repair of
11.3% among patients aged 65—74 years [20]. For emergency
TEVAR, however, published mortality rates range from 17.0%
to 27.9% [18,21], which is markedly higher than the 12% found
in the present series. In contrast, open repair of ruptured
thoracic aneurysms was associated with a mortality of 47.1%
in an age-matched population [20], which however did not
include urgent, non-ruptured cases (35% in our series). Open
repair was performed in 78 patients during the same time
period in our institution and was associated with an early
mortality of 9%. However, patients were younger in average
(61 years) and only 10% were treated emergently.
Early revisions were needed in 16% and 19% of patients,
respectively, and affected both cohorts equally. Half of the
revisions were due to endoleaks and the associated need to
extend the stent-graft. Incidence of early endoleaks ranges
from 0% to 23% in the literature [6] and learning curve,
anatomic complexity of the pathology and reliability of
intraoperative imaging have been implicated as important
factors [6]. Our series started in 2001 and included the
learning curve of the team. However numbers are too small
to ascertain a corresponding trend. Although access-related
revisions are needed more often after open repair [20] (14%
during the corresponding period in our institution), the
reason for a revision seems less important from a patient’s
perspective, which relativises the common belief into the
advantages of a minimally invasive access in this respect.
Mid-term survival was assessed up to three years with no
differences between the treatment cohorts. Results were
consistent with findings in the literature, where 1-year
survival rates ranged between 76.2% and 81.6% [2,7,18,22]
(Fig. 1). In the elective TEVAR cohort a small early survival
benefit during the perioperative period was observed,
although it was not statistically significant.
The insufficiency of assessing outcome of dedicated
vascular therapies simply by morbidity and mortality rates
has only recently been recognised [8]. Health related QoL is
an additional yet crucial outcome dimension since it takes
into account the most important perspective, the patient’s.
Indeed, for the individual survivor, health related QoL might
subjectively be the single most important determinant of
treatment success, since QoL subsumes the relative impor-
tance of all intervention-related sequelae. In surgery of the
thoracic aorta long-term QoL has mainly been assessed for
OAR [9,10], since most TEVAR series were either quite small
or did not review sufficient follow-up periods. Systematic
comparisons of long-term QoL after TEVAR and thoracic OAR
are still lacking, although randomised controlled investiga-
tions of QoL after EVAR and OAR of the abdominal aorta have
been performed [23,24].
For reasons alluded to above, TEVAR is increasingly
performed under emergency conditions with significant
benefits for the patients [2]. Hence, the impact of the
urgency on long-term QoL after TEVAR is of interest.
Obviously patients cannot be randomised to emergency or
elective situations. Therefore a randomised controlled
investigation of this issue is impossible to conduct. In our
series, however, equal numbers of patients were treated by
emergency and elective TEVAR by the same surgical staff
during the observed study period giving a unique opportunity
for such a comparison. Although baseline characteristics of
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comparable (Table 1), this probably constitutes the best
possible approximation of a controlled investigation so far.
The SF-36 questionnaire, as used in this study, is a broadly
accepted tool for QoL assessment because of its generic
design which renders it widely applicable [8]. It has been
used successfully for QoL assessment in vascular patients
before [16]. Even more importantly, it has reliably been
validated for statistical adjustment for age and gender of the
investigated population [12,13]. Thereby, it allows for
meaningful z testing against a standard Western European
control population.
It is common to argue that an unequal distribution of
underlying mental disorders might skew the individually
experienced QoL unfairly and independently of the assessed
influences such as illness or intervention. A comparable score
in the domain mental health therefore is generally regarded
as a precondition for comparability. In our series, both
elective and emergency TEVAR patients not only scored in the
same range (97 [78—121] vs 106 [87—113], p = 0.60, by
Mann—Whitney U test) but also in the centre of what is
perceived as normal in an age- and gender-adjusted standard
population (i.e. 85—115, Fig. 2).
Mid-term health related QoL of the total collective of our
study was lower than what would be expected in an age- and
gender-matched standard population. On integrated physical
and emotional QoL scores, no differences were found
between treatment cohorts. There was no difference in
duration of follow-up between the treatment cohorts, which
equalises possible extrinsic influences. However, like in QoL
assessments of thoracic OAR patients [9,10], limitations were
mainly found in both physical and emotional role functions
and were more pronounced after emergency TEVAR. It is
important to note that any differences in emotional role
function could not be reproduced in the HADS questionnaire,
which focuses specifically on aspects of anxiety and
depression. Here, the results were comparable in both
treatment cohorts. Astonishingly however, emergency TEVAR
patients showed a tendency to score better in the aspects
bodily pain and general health. This could be related to the
fact that patients recovering from a severe and overtaking
illness, like a life-threatening emergency, may experience a
relatively better convalescence than elective patients that
might mainly be reflected in these two dimensions. Further
limitations were found in physical functioning and vitality.
4.1. Limitations of study
Some methodological limitations must be cautiously
considered when interpreting the data of this series.
Although based on prospective data collection, analysis
was post hoc and observational. Thus, all limitations of a non-
randomised study design are possibly present, and a direct
comparison of study cohorts must be judged very cautiously.
Although demographic characteristics seemed acceptably
similar except for hyperlipidaemia (Table 1), a type II error
cannot be ruled out considering the small numbers, and
absence of evidence is certainly not evidence of absence.
Control of QoL assessment, however, was strived for in
various ways and included, as elaborated above, choice of a
validated, generic assessment tool, adjustment for age andgender and z testing against a standard population rather
than direct comparisons. Moreover, the vast overlap of
findings between the treatment cohorts (Figs. 2 and 3)
supports the interpretation that urgency of TEVAR was not
associated with significant impact on mid-term QoL. Another
concern is that non-response to questionnaire surveys may
introduce bias, mostly because patients with worse outcome
might be less likely to respond [25]. Indeed, 8 of 11 non-
responders refused to give a reason. This is an intrinsic
shortcoming of this study type which has not yet been solved
satisfactorily [25]. However, the return rate in our study was
71% which is markedly above average and probably reflects a
pronounced emotional involvement of this patient popula-
tion with their condition [25]. This return can be considered
an acceptable representation of surviving patients, and QoL
was probably, if anything, overestimated which corroborates
the interpretation that mid-term QoL was impaired after
TEVAR as compared to the normal population. More
importantly, return was identical between the groups (70%
vs 72%); therefore any potential bias can be assumed similar
between the two groups. A last area of concern is the length
of follow-up, which covered two and a half years in the
present study. It is an argument whether close surveillance
programs after endovascular repair impairs long-term QoL.
Indeed, patients were seen in annual follow-up visits, which
affected both cohorts equally. EVAR trial 1 found no
secondary changes in QoL up to four years after endovascular
repair despite a similar follow-up program [23], and the
DREAM trial found no association between surveillance
intensity and mid-term QoL [24]. Nevertheless, longer
follow-up data are needed to answer this question for
TEVAR. An important factor towards improved acceptance of
follow-up surveillance might be continuous information and
guidance of the patients by their general practitioners.
We conclude that TEVAR of the diseased thoracic down-
stream aorta provides excellent results under both, elective
and particularly emergency conditions, even though mid-
term QoL may be impaired as compared to an age- and
gender-matched standard population. However, urgency of
the accomplished procedure does not seem to influence
resulting mid-term QoL.Acknowledgement
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